Luvaminos

AMY (CG) / LUV RT

A research peptide blend of two lipidated, acylated synthetic peptides.

Quick answers

What is AMY (CG) / LUV RT?

AMY (CG) / LUV RT is a research peptide blend of two lipidated, acylated synthetic peptides. It is a blend of AMY (CG) and LUV RT.

How much published research cites AMY (CG) / LUV RT?

The Luvaminos AMY (CG) / LUV RT record cites 10 published references, dated 2021 to 2026. Each is listed on this page with a link to its source.

Does Luvaminos test AMY (CG) / LUV RT, and where is the certificate?

Luvaminos does not currently stock AMY (CG) / LUV RT. Every peptide lot Luvaminos sells is tested by Freedom Diagnostics Testing, PLLC, an independent laboratory, and its certificate is published at luvaminos.com/coa under the lot number printed on the vial.

How is AMY (CG) / LUV RT powder stored?

Sealed AMY (CG) / LUV RT powder: -20°C or below; lyophilized powder typically stable up to 24 months in sealed, desiccated vials. AMY (CG): high fibrillation propensity at neutral pH; avoid freeze-thaw cycles. protect from light and moisture.

Molecular Profile

Type
Peptide blend

Components

AMY (CG)

Molecular formula
C194H312N54O59S2
Molecular weight
~4,409 g/mol
CAS number
1415456-99-3

LUV RT

Mechanism & Target Class

A blend of two lipidated, modified synthetic peptides. In each component, fatty-acid conjugation confers reversible albumin binding and extended plasma half-life. Non-coded residue substitutions in both peptides confer resistance to circulating proteases, and each engages class B G protein–coupled receptors as characterized in cryo-EM structural studies.

Storage & Handling

Lyophilized
-20°C or below; lyophilized powder typically stable up to 24 months in sealed, desiccated vials.
Handling
AMY (CG): high fibrillation propensity at neutral pH; avoid freeze-thaw cycles. protect from light and moisture.

References (10)

  1. Reviews

    1

    Walker CS, Aitken JF, Amarsingh GV, Zhang S, Cooper GJS, et al. (2025). Nature Reviews Endocrinology

    DOI: 10.1038/s41574-025-01125-9

  2. 2

    Alfaris N, Waldrop S, Johnson V, Boaventura B, Kendrick K, Stanford FC. (2024). EClinicalMedicine

    DOI: 10.1016/j.eclinm.2024.102782PubMed 39281096

  3. 3

    D'Ascanio AM, Mullally JA, Frishman WH. (2024). Cardiology Reviews

    DOI: 10.1097/CRD.0000000000000513PubMed 36883831

  4. 4

    Chetty AK, Rafi E, Bellini NJ, Buchholz N, Isaacs D. (2024). Endocr Pract

    DOI: 10.1016/j.eprac.2023.12.010PubMed 38122931

  5. Clinical

    5

    Nielsen MJF, Becker NP, Duus HHH, Kirkeby K, Lauenborg BW, Low B, Svolgaard O, Witten L. (2026). Clinical Pharmacokinetics

    DOI: 10.1007/s40262-026-01654-0

  6. 6

    Lau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, et al. (2021). Lancet

    DOI: 10.1016/S0140-6736(21)01751-7PubMed 34798060

  7. Primary research

    7

    Gu YM, Yuan QN, Li X, He QL, Xu WC, Zhang XT, Lu WM, et al. (2026). Acta Pharmacologica Sinica

    DOI: 10.1038/s41401-025-01635-2

  8. 8

    Cao J, Belousoff MJ, Johnson RM, Keov P, Fletcher MMR, Stockholst VL, Yumul RE, Christopoulos A, Reedtz-Runge S, Walker CS, et al. (2025). Nature Communications

    DOI: 10.1038/s41467-025-58680-y

  9. 9

    Kruse T, Hansen JL, Dahl K, Schäffer L, Sensfuss U, Poulsen C, Schlein M, Hansen AM, Jeppesen CB, de la Cour CD, et al. (2021). Journal of Medicinal Chemistry

    DOI: 10.1021/acs.jmedchem.1c00565

  10. 10

    Carvas AO, Leuthardt A, Kulka P, Lommi G, Hassan S, Coester B, et al. (2025). EBioMedicine

    DOI: 10.1016/j.ebiom.2025.105836PubMed 40609154

Related compounds

About AMY (CG) / LUV RT

What is AMY (CG) / LUV RT?

AMY (CG) / LUV RT is a research peptide blend of two lipidated, acylated synthetic peptides.

How is AMY (CG) / LUV RT powder stored?

-20°C or below; lyophilized powder typically stable up to 24 months in sealed, desiccated vials.